Hasil Pencarian - Toru Yoshimura

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review

    Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review oleh Hiroshi Yasuda, Masatoshi Nakagawa, Hirofumi Kiyokawa, Eisaku Yoshida, Toru Yoshimura, Naohiko Koshikawa, Fumio Itoh, Motoharu Seiki

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Development of a quantitative thyroid-stimulating hormone assay system for a benchtop digital ELISA desktop analyzer

    Development of a quantitative thyroid-stimulating hormone assay system for a benchtop digital ELISA desktop analyzer oleh Yoshiyuki Arai, Dong Wang, Miki Takeuchi, Sosuke Utsunomiya, Takuma Degawa, Atsushi Kai, Hisashi Ichikawa, Ryotaro Chiba, Toru Yoshimura

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Focal segmental glomerulosclerosis in which urinary protein improved after surgical treatment for acromegaly: a case report

    Focal segmental glomerulosclerosis in which urinary protein improved after surgical treatment for acromegaly: a case report oleh Arina Yamasaki, Daisuke Bito, Erina Eto, Keiichiro Matsumoto, Megumi Nakamura, Junji Miyazaki, Kenichi Matsumoto, Masanori Masuda, Daisuke Mori, Toru Yoshimura

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer

    Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer oleh Masatoshi Nakagawa, Takashi Karashima, Masayuki Kamada, Eisaku Yoshida, Toru Yoshimura, Masanori Nojima, Keiji Inoue, Taro Shuin, Motoharu Seiki, Naohiko Koshikawa

    Diterbitkan 2017-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Development of an automated chemiluminescent immunoassay for cancer antigen 72–4 and the evaluation of its analytical performance

    Development of an automated chemiluminescent immunoassay for cancer antigen 72–4 and the evaluation of its analytical performance oleh Fusamitsu Yanagihara, Hideaki Okura, Hisashi Ichikawa, Takuma Shirakawa, You Pan, Bailin Tu, Zhihong Lin, Ryan Bonn, Sridevi Kurella, Beth Schodin, Toru Yoshimura

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer

    Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer oleh Takashi Karashima, Susumu Umemoto, Takeshi Kishida, Kimito Osaka, Masatoshi Nakagawa, Eisaku Yoshida, Toru Yoshimura, Masahiko Sakaguchi, Hiroyuki Nishimoto, Mami Tai, Keiji Inoue, Motoharu Seiki, Naohiko Koshikawa, Taro Shuin

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Development of a Fully Automated Desktop Analyzer and Ultrahigh Sensitivity Digital Immunoassay for SARS-CoV-2 Nucleocapsid Antigen Detection

    Development of a Fully Automated Desktop Analyzer and Ultrahigh Sensitivity Digital Immunoassay for SARS-CoV-2 Nucleocapsid Antigen Detection oleh Ryotaro Chiba, Kei Miyakawa, Kotaro Aoki, Takamitsu J. Morikawa, Yoshiki Moriizumi, Takuma Degawa, Yoshiyuki Arai, Osamu Segawa, Kengo Tanaka, Hideji Tajima, Susumu Arai, Hisatoshi Yoshinaga, Ryohei Tsukada, Akira Tani, Haruhito Fuji, Akinobu Sato, Yoshikazu Ishii, Kazuhiro Tateda, Akihide Ryo, Toru Yoshimura

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: